Pulmonx Corporation Total Liabilities 2019-2024 | LUNG
Pulmonx Corporation total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Pulmonx Corporation Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $59 |
| 2022 | $40 |
| 2021 | $42 |
| 2020 | $38 |
| 2019 | $36 |
| 2018 | $42 |
| Pulmonx Corporation Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $73 |
| 2024-06-30 | $71 |
| 2024-03-31 | $54 |
| 2023-12-31 | $59 |
| 2023-09-30 | $59 |
| 2023-06-30 | $59 |
| 2023-03-31 | $57 |
| 2022-12-31 | $40 |
| 2022-09-30 | $39 |
| 2022-06-30 | $41 |
| 2022-03-31 | $41 |
| 2021-12-31 | $42 |
| 2021-09-30 | $44 |
| 2021-06-30 | $39 |
| 2021-03-31 | $39 |
| 2020-12-31 | $38 |
| 2020-09-30 | $278 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2018-12-31 | $42 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||